| Name | Title | Contact Details |
|---|
Situated alongside Lake Champlain, we are the largest private non-profit human services organization in the State of Vermont. Since 1865, Howard Center has been helping people and communities thrive by providing supports and services to address mental health, substance use, and developmental needs. Today, we employ 1,600 staff providing services in 60 locations serving more than 16,000 community members annually. Through our competitive and award-winning benefits, work-life balance and equal opportunity employment, we build teams of dedicated, passionate individuals who embrace our mission and are committed to making a lasting contribution to the lives of the people we serve. The world around us continues to change every day. At Howard Center, we believe it is vital to face new and unanticipated obstacles with all of our voices. We welcome applicants of all racial and ethnic backgrounds, identities and expressions, religious beliefs, disabilities, age groups, lived experiences and perspectives. In order to provide the best care for our clients, our aim is for our staff to be a reflection of the community we serve.
Essilor Canada Ltd. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Quality Council of Alberta is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vono Medical Supplies is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Fractyl, we are focused on improving the health of people with Type 2 diabetes. We`ve created an innovative clinical procedure based on new insights into the root cause of the disease. We are currently engaged in clinical trials designed to prove that our innovative procedure can dramatically improve glucose control and reduce the need for additional medications. Our mission is to set people free from the daily burdens of Type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.